Status:
COMPLETED
A Safety Study Of Pregabalin In Fibromyalgia
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate the safety of pregabalin in patients with fibromyalgia.
Eligibility Criteria
Inclusion
- Patients must meet the ACR criteria for fibromyalgia (ie, widespread pain present for at least 3 months, and pain in at least 11 of 18 specific tender point sites.
- Patients must complete the double-blind study.
Exclusion
- Patients who experienced a serious adverse event during the previous fibromyalgia study, which was determined to be related to the study medication.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00282997
Start Date
February 1 2006
End Date
October 1 2006
Last Update
January 22 2021
Active Locations (72)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Little Rock, Arkansas, United States
2
Pfizer Investigational Site
Fresno, California, United States
3
Pfizer Investigational Site
La Jolla, California, United States
4
Pfizer Investigational Site
Northridge, California, United States